Uniplan Investment Counsel, Inc. Axogen, Inc. Transaction History
Uniplan Investment Counsel, Inc.
- $943 Million
- Q3 2025
A detailed history of Uniplan Investment Counsel, Inc. transactions in Axogen, Inc. stock. As of the latest transaction made, Uniplan Investment Counsel, Inc. holds 158,738 shares of AXGN stock, worth $3.75 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
158,738
Previous 184,969
14.18%
Holding current value
$3.75 Million
Previous $2.01 Million
41.13%
% of portfolio
0.3%
Previous 0.22%
Shares
3 transactions
Others Institutions Holding AXGN
# of Institutions
186Shares Held
41.6MCall Options Held
86.4KPut Options Held
14.3K-
First Light Asset Management, LLC Edina, MN5.81MShares$137 Million12.43% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$76.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.68MShares$63.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.43MShares$57.5 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO1.96MShares$46.3 Million0.75% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $1B
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...